NODAGATOC, a new chelator-coupled somatostatin analogue labeled with [67/68Ga] and [111In] for SPECT, PET, and targeted therapeutic applications of somatostatin receptor (hsst2) expressing tumors

Bioconjugate Chemistry

Volumn 13, Issue 3, 2002, Pages 530-541

  Eisenwiener, Klaus Peter ^a   Prata, M I M ^b   Buschmann, I ^a   Zhang, Han Wen ^a   Santos, A C ^c   Wenger, Sandra ^d   Reubi, Jean Claude ^d   Mäcke, Helmut R ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; PEPTIDES; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; RATS; SYNTHESIS (CHEMICAL);

HIGH AFFINITY; N TERMINUS; OCTREOTIDE; SOLID PHASIS; SOLID-PHASE; SOMATOSTATIN RECEPTORS; SYNTHESISED; TARGETED THERAPEUTICS; THERAPEUTIC APPLICATION; TRIAZACYCLONONANE;

TUMORS;

MUS MUSCULUS; PROCHELATOR;

1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID; 1,4,7-TRIAZACYCLONONANE-N,N',N''-TRIACETIC ACID; 3 TYR OCTREOTIDE; 3-TYR-OCTREOTIDE; DRUG DERIVATIVE; GALLIUM; HETEROCYCLIC COMPOUND; INDIUM; LIGAND; OCTREOTIDE; PEPTIDE FRAGMENT; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN RECEPTOR;

ANIMAL; ARTICLE; CELL CULTURE; CHEMISTRY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG STABILITY; FEMALE; IN VITRO STUDY; LIVER; METABOLISM; MOUSE; NUDE MOUSE; PANCREAS TUMOR; PROTEIN BINDING; RAT; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE DISTRIBUTION;

ANIMALS; CELLS, CULTURED; DRUG STABILITY; FEMALE; GALLIUM RADIOISOTOPES; HETEROCYCLIC COMPOUNDS; INDIUM RADIOISOTOPES; LIGANDS; LIVER; MICE; MICE, NUDE; OCTREOTIDE; PANCREATIC NEOPLASMS; PEPTIDE FRAGMENTS; PROTEIN BINDING; RADIOPHARMACEUTICALS; RATS; RECEPTORS, SOMATOSTATIN; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0035999707     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc010074f     Document Type: Article

References (48)

1. Octreotide
2. Diagnostic applications of radiolabeled peptides in nuclear endocrinology
3. A ticket to ride: Peptide radiopharmaceuticals
4. Receptor targeting for tumor localisation and therapy with radiopeptides
5. 99mTc
6. 99mTc-Labeled small peptides as diagnostic radiopharmaceuticals
7. Neuropeptide receptors in health and disease: The molecular basis for in vivo imaging
8. Radiolabeled peptides: Now and the future
9. 3-octreotide
10. 3]-octreotide: The Rotterdam experience with more than 1000 patients
11. Radiometal-labeled macrocyclic chelator-derivatised somatostatin analogue with superb tumour-targeting properties and potential for receptor-mediated internal radiotherapy
12. Gallium-67/gallium-68-[dfo]-octreotide - A potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: Synthesis and radiolabeling in vitro and prelimainary in vivo studies
13. 68Ga] labeled DFO-Octreotide (SDZ 216-297) for PET studies of somatostatin receptor positive tumors
14. Somatostatin analogues labeled with different radionuclides
15. 3]octreotide, a promising somatostatin analogue for radionuclide therapy
16. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use
17. Radiometal-labeled agents (Non-Technetium) for diagnostic imaging
18. Gallium radiopharmaceutical chemistry
19. The gallium-deferoxamine complex: Stability with different deferoxamine concentrations and incubation conditions
20. Novel gallium(III) complexes transported by MDR1 P-glycoprotein: Potential PET imaging agents for probing P-glycoprotein-mediated transport activity in vivo
21. A convenient synthesis of novel bifunctional prochelators for coupling to bioactive peptides for radiometal labeling
22. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas
23. In vitro identification of vasoactive intestinal peptide receptors in human tumors: Implications for tumor imaging
24. 3]octreotide by mouse and human pituitary tumor cells: Increase by unlabeled octreotide
25. 3]octreotide: Peptides for somatostatine receptor-targeted scintigraphy and radionuclide therapy
26. 1-octreotide synthesis
27. Preclinical comparison in AR4-2J tumor bearing-mice of four radiolabeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-somatostatin analogues for tumor diagnosis and internal radiotherapy
28. 64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors
29. In Vitro and In Vivo Evaluation of Copper-64-Octreotide Conjugates
30. 3-octreotate. A new somatostatin analogue with improved target tissue uptake
31. 86Y-DTPA-Octreotide
32. 111InDTPA-octreotide
33. 3-octreotide: First results in patients with meningiomas
34. 68Ga-DOTATOC: Preliminary data
35. Synthesis of 2-(p-Thiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic Acid: Application of the 4-Methoxy-2,3,6-trimethylbenzenesulfonamide protecting group in the synthesis of macrocyclic polyamines
36. Synthesis of C- and N-functionalised derivatives of 1,4,7-Triazacyclononane-1,4,7-triacetic Acid (NOTA), 1,4,7,10-Tetra-azacyclododecane-1,4,7,10-tetrayltetraacetic Acid (DOTA), and Diethylenetriaminepenta-acetic Acid (DTPA): Bifunctional complexing agents for the derivatisation of antibodies
37. Synthesis of novel 1,4,7-Triazacyclononane-N,N′,N″-triacetic acid derivatives suitable for protein labeling
38. A Direct Synthesis of a bifunctional chelating agent for radiolabeling proteins
39. Improved synthesis of the bifunctional chelating agent 1,4,7,10-Tetraaza-N-(1-carboxy-3-(4-nitrophenyl)propyl)-N′,N″, N‴-tris(acetic acid)cyclododecane (PA-DOTA)
40. Unexpected selectivity in the alkylation of polyazamacrocycles
41. 1,4,7-Triazacyclononane-1-succinic acid-4,7-diacetic acid (NODASA): A new bifunctional chelator for radio gallium-labeling of biomolecules
42. Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenides
43. Structure and solution stability of indium and gallium complexes of 1,4,7-Triazacyclononanetriacetate and of Yttrium complexes of of 1,4,7,10-Tetraazacyclododecanetetraacetate and related ligands: Kinetically stable complexes for use in imaging and radioimmunotherapy. X-ray molecular structure of the indium and gallium complexes of 1,4,7-Triazacyclononane-1,4,7-triacetic Acid
44. Stabilities of the Fe(III), Ga(III) and In(III) chelates of N,N′,N″-triazacyclononanetriacetic acid
45. Endocytosis and recycling of G protein-coupled receptors
46. Fates of endocytosed somatostatin sst2 receptor and associated agonists
47. 64Cu-labeled somatostatin analogues in vitro and in tumor-bearing rat model: Evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy